Share this post on:

Product Name :
UNC-2881

Search keywords :
UNC2881

drugId :
null

Target Vo:
Tyrosine-protein kinase Mer

Target Vo Short Name :
MerTK

Moa_Name:
Tyrosine-protein kinase Mer inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of North Carolina At Chapel Hill

Active Company_Name :
University Of North Carolina At Chapel Hill

Active Indication_Name:
Thrombosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AMPK alpha 1 (Ser496) Antibody
ICAM1 Antibody (YA725)
Vinculin Antibody: Vinculin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 124 kDa, targeting to Vinculin. It can be used for WB,ICC/IF,IP,IHC assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related